Abbott
VC Fund
Illinois City, United States
Abbott is a VC fund in Illinois City focused on Health Care and Medical Device. Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV, Synthroid, a synthetic thyroid hormone, Depakote, an anticonvulsant drug, and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis,and more.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Abbott invests in
Health CareMedical DeviceMedicalBiotechnologyEducation
Stages Abbott invests in
GrantSeries BSeries CSeries ASeries D
Countries Abbott invests in
United StatesGermany
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Farrell
|
|||
James McCarter
|
|||
James McCarter
|
|||
Jennifer Ranaldi
|
|||
Julie Tyler
|
|||
| See all 13 contacts → | |||
Investment Focus
Industry
- Health Care 8 (57%)
- Medical Device 6 (43%)
- Medical 3 (21%)
- Biotechnology 3 (21%)
- Education 2 (14%)
Stage
- Grant 4 (29%)
- Series B 3 (21%)
- Series C 3 (21%)
- Series A 1 (7%)
- Series D 1 (7%)
Country
- United States 11 (79%)
- Germany 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
James Farrell
Member of Board of Directors
|
Member of Board of Directors | Total investments: 0 | Find email | |
|
James McCarter
Medical Director, New Analyte Ventures, Abbott Diabetes Care
|
Medical Director, New Analyte Ventures, Abbott Diabetes Care | Total investments: 0 | Find email | |
|
James McCarter
Medical Director, New Analyte Ventures, Abbott Diabetes Care
|
Medical Director, New Analyte Ventures, Abbott Diabetes Care | Total investments: 0 | Find email | |
|
Jennifer Ranaldi
Structural Heart, Mitraclip
|
Structural Heart, Mitraclip | Total investments: 0 | Find email | |
|
Julie Tyler
Senior Vice President, Vascular
|
Senior Vice President, Vascular | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NVision Quantum Technologies
|
NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $38M / Series B / May 13, 2026 | |
Senseonics
|
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. | $77.8M / Post-IPO Equity / May 15, 2025 | |
University of Nebraska
|
The official LinkedIn page for the University of Nebraska, the only public research university in the state of Nebraska. | $1M / Grant / Dec 07, 2024 | |
University of Nebraska-Lincoln
|
The largest university in the state, the University of Nebraska at Lincoln offers academic programs and research that have long placed it at the forefront of education.For example, University of Nebraska is one of the first universities to establish a major in Digital Humanities, offered through the English Department.In the samedepartment, graduate students may undertake UNL’s prestigious MFA program in Creative Writing, which has leading writers among its faculty and is also responsible for founding one of the country’s most respected university literary publications.On the fine arts end of things, UNL boasts top museums and galleries with collections by some of the world’s most revered artists. UNL also has a natural history museum, which features fossils and other types of ancient excavations.Additional areas of study include:*Agricultural Sciences *Architecture *Education *Engineering *Law *Liberal Arts and Humanities *Performing Arts *Mass CommunicationsUNL has long been distinguished for its research activity as well, conducting valuable research in a variety of scientific and other fields. | $1M / Grant / Dec 05, 2024 | |
Easterseals
|
Since its founding in 1944, EasterSeals has had one mission: ensuring that children and adults with disabilities have equal opportunities to live, learn, work and play. Through the years Easter Seals has been continually developing new programs and innovative approaches to meet the specific needs of its clients. One of Easter Seals’ mostenduring programs has provided a summer camp experience for children with disabilities for more than 60 years. Easter Seals currently serves hundreds of children every summer in our camping program at Agassiz Village in Maine. Through the Youth Leadership program, Easter Seals also offers opportunities for young people with disabilities to discover their personal abilities and skills. Service learning activities help generate feelings of importance and self-worth, while encouraging them to become forces for change in their communities. In 1988, Easter Seals recognized the potential benefits that technology holds for children and adults with disabilities. Its assistive technology program began with a few donated computers and one specialist. Today, the program has more than 20 specialists and utilizes a wide array of software, hardware and adaptive devices. Easter Seals is now a national leader in using technology to expand independence for people with disabilities at home, in school and in the workplace. Numerous programs help people access the assistive technology they need. At the Assistive Technology Regional Centers, people with disabilities can see, try out and borrow devices in order to make more informed decisions about technology that will meet their needs. The Massachusetts Assistive Technology Loan Program provides access to low-interest cash loans for the purchase of assistive devices and services that will improve the quality of life for people with disabilities. Our Long-Term Device Loan Program provides people with assistive devices that cost less than $500. The devices are available free of charge to qualified Massachusetts residents with disabilities and their families. Easter Seals Rehabilitation Services offers physical, occupational and speech therapy to people in homes, schools, nursing homes, day care centers and clinics. The Easter Seals Job Training and Employment program helps people with disabilities develop the skills they need in order to get and keep jobs in today’s competitive workplace. The program offers individualized vocational rehabilitation, job training and employment services to students and adults. Easter Seals staff members also answer thousands of questions every year through a disability resource information center. And advocates work to help state legislators and government officials understand and meet all the needs of men, women and children with disabilities. In 2014, Easter Seals services benefited more than 26,000 Massachusetts residents with disabilities, their families, teachers and employers. Easter Seals and its affiliate organizations are 501(c)(3) nonprofit organizations. | $750K / Grant / Jun 22, 2022 | |
Howard University
|
Howard University is a nationally acclaimed, research-oriented institution, which was founded to provide stellar education to African-American students. Howard may be the most well-known Historically Black University (HBCU).Located in the culturally rich U Street/Shaw neighborhood of Washington, DC, Howard finds itself surrounded bypolitics and artists. Students come to Howard not merely for a rigorous education, but to have a well-rounded, culturally inspired, politically informed university experience.Howard offers bachelor’s degrees in a wide range of studies, has graduate programs, and offers doctorate programs in law, medicine and pharmaceutical studies. Students are able to take advantage of research studies to build their resumes, as well as study abroad programs to enlighten their global perspectives.Howard University is a competitive institution that boasts the some of the best professors and professionals in their field. Faculty and students alike are proud to be members of such a prestigious and historically significant institution.If you’re looking for a first class education in the heart of the nation’s capital, Howard University may have an academic future for you. | $1M / Grant / Dec 09, 2021 | |
Bigfoot Biomedical
|
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical deviceecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care.Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service. | $55.1M / Series C / Jan 13, 2020 | |
Alere
|
Alere Inc., formerly Inverness Medical Innovations, Inc., provides diagnostics and health management solutions. The Company's products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women's health. Its brands range from over-the-counter tests to lab-based diagnostics to integrated home monitoringsolutions. The Company's brands include Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, BinaxNOW, Cholestech LDX, Clearview iFOB Complete, Determine HBsAg, DoubleCheckGold and ImmunoComb. The Company has operations in North America, Europe and Middle East, Asia Pacific, and Latin America and Africa. | Post-IPO Equity / Aug 14, 2017 | |
SetPoint Medical
|
SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $15M / Series C / Sep 08, 2015 | |
Respicardia
|
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing patternduring sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™. | $27M / Series C / Aug 25, 2010 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
EdTech Investors
18,221 investors
Education Investors
13,563 investors
Medical Device Investors
11,047 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
FAQ
What does Abbott invest in?
Abbott invests primarily in Health Care, Medical Device and Medical startups, most often at Grant and Series B stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Abbott?
Public channels for Abbott include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Abbott?
The team at Abbott includes James Farrell (Member of Board of Directors), James McCarter (Medical Director, New Analyte Ventures, Abbott Diabetes Care) and James McCarter (Medical Director, New Analyte Ventures, Abbott Diabetes Care), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
